Hester Biosciences submits transcript of earnings conference call

10 Feb 2020 Evaluate

Hester Biosciences has informed that the Company submitted a transcript of Earnings Conference Call held by the Management of the Company with investors on Friday, 7 February 2020 at 2.00 pm to discuss the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended on 31 December 2019.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1762.15 -12.05 (-0.68%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.